摘要
目的：了解乌鲁木齐市天山区成年慢性肾脏病(CKD)的流行病学特征。
方法：以分层多级整群抽样法,对乌鲁木齐市天山区4个社区的2131名35岁以上常住居民进行问卷调查、体格检查和实验室检查。
结果：在2131名资料完整的居民中,经年龄、性别校正后,白蛋白尿的患病率为2.63%(95%CI：1.78%-3.48%)；血尿的患病率为7.43%(95%CI: 6.11%-8.75%)；肾功能下降的患病率为1.72%(95%CI：1.08%-2.35%)。该人群CKD的患病率为9.99%(95%CI：8.47%-11.55%),知晓率为2.44%。多因素Logistic回归显示：白蛋白尿、血尿、年龄增加10岁、高尿酸血症与肾功能下降独立相关；血尿、肾功能下降与白蛋白尿独立相关；白蛋白尿、肾功能下降、女性与血尿独立相关。
结论：在我国西部大城市中,成人CKD的患病率为9.99%,知晓率为2.44%,CKD的危险因素与我国大城市及西方发达国家类似。
目的：探讨乌鲁木齐市天山区成人慢性肾脏病社区干预模式及效果评价。
方法：以流行病学调查确定的CKD患者及高危人群为对象,将CKD患者及高危人群设定为干预组,非CKD人群为对照组,对照组进行基础干预,干预组进行基础干预加综合干预,干预期为2年并对干预效果进行评价。
结果：对照组中接受健康教育、对CKD及其他慢性非传染性疾病的知晓率、对CKD危险因素的认知率等描述指标经干预和随访后,差异有统计学意义(P<0.05)；而吸烟、体育锻炼和对其它疾病控制情况等描述性指标经干预和随访后,差异无统计学意义(P>0.05)。在9项检测指标中通过干预和随访后,差异无统计学意义(P>0.05)。
干预组中对CKD及其他慢性非传染性疾病的知晓率、对CKD危险因素的认知程度和服药依从性等描述性指标经干预和随访后,差异有统计学意义(P<0.05)；在接受健康教育和对CKD并发症的认知率,部分差异无统计学意义(P>0.05),部分差异均有统计学意义(P<0.05)。而吸烟、体育锻炼、饮食依从性、对CKD的干预率、对CKD的控制和对其它疾病控制情况等6项描述性指标经干预和随访后,差异无统计学意义(P>0.05)。血脂和血尿酸经干预和随访后,差异均有统计学意义(P<0.05)；血糖部分差异无统计学意义(P>0.05),部分差异均有统计学意义(P<0.05)；其余6项检测指标通过不同的干预和多次随访后,差异无统计学意义(P>0.05)。
结论：通过对对照组实施基础干预和对干预组实施基础干预加综合干预,显示出社区综合干预模式是防治CKD的有效措施。
Objective:To investigate the prevalence of chronic kidney disease (CKD) and risk factors in the adult population in Tianshan district of Urumqi
Methods:2131 residents from 4 communities in Tianshan district of Urumqi city were randomly selected by using a stratified, multistage sampling. All residents were interviewed and tested for morning spot urine of albumin to creatinine ratio (ACR) (abnormal:≥30 mg/g); morning spot urine dipstick of hematuria (abnormal:> 3 red blood cells/Hp or greater) and pyuria (abnormal:> 5 White blood cells/Hp) confirmed by urine microscopy; Reduced renal function-estimated glomerular filtration rate (e GFR) by abbreviated MDRD equation eGFR[abnormal:< 60 ml-min-1?(1.73 m2)-1]. The associations of kidney damage indicators with age, gender, hypertension, diabetsmellitus, smoking, income, education, cholesterol, triglyceride and smoking were detected by questionnaire and physical examination.
Results:Eligible data of 2131 subjects were collected in the study.. After the adjustment of age and gender componen, the prevalence of albuminuria was detected in 2.63%(95%CI:1.78%-3.48%) of subjects, hematuria in 7.43%(95%CI:6.11%-8.75%) and reduced renal function in 1.72%(95%CI:1.08%-2.35%). Approximately 9.99% (95%CI:8.47%-11.55%) subjects had at least one indicator of kidney damage. Multivariate logistic regression display:Albuminuria, hematuria, age and hyperuricemia were independently associated with reduced renal function. Hematuria and reduced renal function were independently associated with albuminuria. Albuminuria, reduced renal function and female were independently associated with hematuria.
Conclusions:The prevalence of chronic kidney disease is 9.99%and the recognition rate is 2.44%in urban adult population in western china. The risk factors of CKD in adult population in Urumqi city are similar with the metropolis in China and the developed countries.
Population-based studies evaluating the prevalence of kidney damage in different communities have been limited in developing countries. We conducted a population-based screening study in Uygur people of Urumqi that aimed to identify the prevalence and associated risk factors of chronic kidney disease (CKD) in Uygur populations.
Methods. We interviewed 2576 residents (>18 years) from four districts of Urumqi from June 2007 to January 2009 and tested for haematuria, albuminuria and reduced renal function. Associations between age, gender, smoking, diabetes mellitus, hypertension, hyperuricaemia and kidney damage were examined.
Results. There were 2576 subjects enrolled in this study. After standardization for age, the prevalence of albuminuria, haematuria and reduced estimated glomerular filtration rate (eGFR) was3.58%,2.26%and 1.03%, respectively. Approximately 5.65%of the sample population had at least one indicator of kidney damage. Age, diabetes mellitus, hypercholesteremia, hyperuricaemia and hyperlipidaemia were independently associated with CKD.
Conclusions, In the general uygur adult population from Urumqi,5.65%has either proteinuria, haematuria and/or reduced eGFR, indicating the presence of kidney damage, with an awareness of only 1.05%. The high prevalence and low awareness of CKD in this population suggest an urgent need for CKD prevention programmes in Uygur people.
Objective:To set up the community intervention model for chronic kidney disease (CKD) and evalute the effect of the model.
Methods:The CKD patients and non-CKD participants were divided into invention group and control group randomly based on the database of CKD which was established according to the epidemiological study. The comprehensive intervention was conducted on the all participants for one year, then the effect of intervention was evaluated.
Results:After the comprehensive intervention, the awareness rate of chronic kidney disease in non-CKD participants increased by 48.7%, while the CKD patients increased by 33.48%; The percence of smoking in non-CKD participants decreased by 18.04%, while the CKD patients decreased by 30.02%; The recognition rate of rish factors and complication of CKD, compliance with dietary and pharmologic therapy were increased significantly, and the differences showed statistically significant (P<0.05); After comprehensive intervention, both of the systolic blood pressure and the diastolic blood pressure were decreased significantly (P<0.05).
Conclusions:The community intervention is an effective measure for the prevention and control of chronic kidney disease.
引文
1. LysaghtMJ. Maintenance dialysis population dynamics:current trends and bon-tem implications. J Am SocNephrol 2002; 13:37-40.
2. Flowers NT, Croft JB. Hospitalization discharge diagnoses for kidney disease United States,1980-2005. JAMA,2008,299:214.
3. Collins AJ. Cardiovascular mortality in end-stage renal disease. AmJ Med Sci,2003, 325:163-167.
4. CHEN Xiaonong, PAN Xiaoxia, YU Haijin,etal. Prevalence of cardiovascular diseases in patients with chronic kidney diseases.2009,32(9):769-773.
5. Garg AX, Kiberd BA, Clark WF, etal. Albuminuria and renal insufficiency prevalence guides population screening:results from the NHANESⅢ,Kidney Int,2006,61: 2165-2175.
6. Ramirez SP, Mcclellan W, Port FK, et al. Risk factors for proteimuria in a large, multiracial, southest Asian population. J Am SocNephrol,2002,13:1907-1917.
7.张路霞,左力,徐国宾,等.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究.中华肾脏病杂志,2006,22(2)：67-71.
8. LeveyAS, CoreshJ, BalkE, etal. National Kidney Foundation practice guide lines for chronic kidney disease:evaluation, classification, and stratification J. Am J Kindey Dis, 2003,139(2):1372147.
9. Iseki K, Iseki C, Ikemiya Y, etal. Risk of developing end-stage renal disease in acohort of massscreening J. Kidney Int,1996,49(3):806813.
10. Ramirez SP, Mcclellan W, Port FK, etal. Risk factors for protein uria in alarge, multiracial, southeast Asian population J. J Am Soc Nephro 2002,13(7):19071917.
11. Chadban Si, Briganti EM, Kerr PG, etal. Prevalence of kidney damage in Australian adults:the Aus Diab kidney study J. J Soc Nephrol,2003,14 (7Suppl2):S1312S138.
12. Li PK, Kwan BC, Leung CB, etal. Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong asymptomatic renal population and evaluation SHARE program J. Kidney Int,2005, (94):S36-S40.
13. International Federation of Kidney Foundations, International Society of Nephrology, Committee for World Kidney Day. World Kidney Day:anidea whose time has come. Nephrol Dial Transplant,2006,21(3):559-561.
1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA,2007,298 (17):2038-2047.
2. Imai E, HorioM, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by theMDRD equationmodified by a Japanese coefficient. Clin Exp Nephrol,2007,11 (2):156-163.
3. Anonymous. KDOQ I clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, kidney disease outcome quality initiative. Am J Kidey Dis,2002,39 Suppl 2:1-246.
4.于传海,尿液红细胞形态在血尿鉴别诊断中的意义.中外医疗.2008,6：159.
5. 叶应妩,王毓三等主编.全国临床检验操作规程.第3版.中华人名共和国卫生部医政司.2006.
6.马迎春,左力,王海燕,等.肾小球滤过率测定存在的问题与对策.中国医学论坛报,2006.11.9.
7. Ma YC, Zuo, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol,17:2937-44, 2006.
8.全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估.中华肾脏病杂志,2006,22(10)：589-595.
9.金丕焕.回归分析中的一种错误策略.中华预防医学杂志,1998,4：210.
10.张路霞,左力,徐国宾,等.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究.中华肾脏病杂志,2006,22(2)：67-71.
11.王奕,刘娜,王俊,等.上海浦东梅园社区慢性肾脏病流行病学调查.中国实用内科杂志,2008,28(11)：961-963.
12.陈崴,王辉,董秀清,等.广州市城区普通人群中慢性肾脏病的流行病学研究.中华肾脏病杂志,2007,23(3)：149-151.
13. Garg AX, Kiberd BA, Clark WF, et al. Albuminuria and renal in sufficieny prevalence guides population screening:results from the NHANESⅢ. Kidney Int, 2002,61:2165-2175.
14. Ramirez SP, Mcclellam W, Port FK, el at.Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc ephrol,2002,13:1907-1917.
15. Levey AS, Kckarde KU, Tsukamoto Y, el al. Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes(KDIGO) Kidney Int,2005,67:2089-2100.
16. Li PK, Kwan BC, Leung CB. Prevalence of sileng kidney disease in Hong Kong: The Screening for Hong Kong Asymtomatic Renal Population and valuation (SHARE) program. Kidney Int,2005,67(Supp 194):36-40.
17. Sylvia PB, Ramires S, William M, etal. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am SocNephrol,2002,13:1907-1917.
18. U.S.Renal Data System, USRDS 2008 Annual Data Report:Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Disease. Bethesda,2008.
19. Atkins RC. The epidemiololgy of chronic kidney disease. Kidney Int,2005,67 (Supp 194):14-18.
20. Li LSH, Liu ZHH. Epidemiologic data of renal disease from a single unit in china: analysis based on 13519 renal biop sies. Kidney Int,2004,66:920-923.
21. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equation for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephor,2002,13:2140-2144.
22. Hosoya T, Toshima R.Changes in renal function with agin among Japanese. Internmed,1995,34 (6):520-527.
23.王海燕,主编.肾脏病学.3版.北京：人民卫生出版社,2008：2302-2314.
24. CoreshJ, Astor BC, Green T, etal. Prevalance of chronic kidney disease and decreased kidney function in the adult US population:third national health and natrition examination survey [J]. Am J Kidney Dis,2003, 41(1):1-12.
25. EdwardsNL. The role of hyperuricem ia and gout in kidney and cardiovascular disease. Cleve ClinJMed,2008,75Suppl5:S13-16.
26. Hebert LA, Rovin B. Uric acid and cardiovascular risk. N Engl J Med,2009,29;360 (5):540.
27. Duan X, Ling F. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses,2008,7 (3):578-581.
1. Chadban SJ, Brigand EM, Kerr PG et al. Prevalence of kidney damage in Australian adults:the.AusDiab Kidney study. J Am Soc Nephrol 2003; 14:5131-S138
2. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population:Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12
3. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. JAm Soc Nephrol 2006; 17:2275-2284
4. van Dijk PC, Jager KJ, de Charro F et al. Renal replacement therapy in Europe:the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16:1120-1129
5. Xue JL, Ma JZ, Louis TA et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010 J Am Soc Nephrol 2001; 12:2753-2758
6. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classificatioan of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089-2100
7. Lord GM, Tagore R, Cook T et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354:481-482
8. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 2006; 17:2937-2944
9. National Kidney Foundation:K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease:Evaluation, classification, and stratification. Am J Kidney Dis 39(2):S 1-266,2002 (suppl 1)
10. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD:a population study from Beijing. Am J Kidney Dis 2008; 51:373-384
11. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure:the JNC 7 report. JAMA 2003; 289:2560-2572
12. Claw CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans:Third National Health and Nutrition Examination Survey (NHANES III). JAm Soc Nephrol 2002; 13:1338-1349
13. Zhang L, Zuo L, Xu G et al Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 2007; 22: 1093-1099
14. Claw CM, Kiberd BA, Garg AX. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities:results from the Third National Health and Nutrition Examination Survey (NHANES III). Nephron Clin Pract 2007; 105:cl78-cl84
15.Li PK, Kwan BC, Leung CB et al Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl 2005; S36-S40
16. Szeto CC, Lai FM, To KF et al. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am JMed 2001; 110:434-437
17. Shen P, He L, Li Y et al. Natural history and proenostic factors of IgA nephropathy presented with isotated microscoptc hematuria in Chinese patients. Nephron Clin Pract 2007; 106:c 157-c 161
18. Yamagata K, Takahashi H, Tomida C et al. Proenosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening. Nephron 2002; 91:34-42
19. Johnson RJ, Segal MS, Srinivas T et al. Essential hypertension, progressive renal disease, and uric acid:a pathogenetie link? JAm Soc Nehrol 2005; 16:1909-1919
20. Kanellis J, Feig DI, Johnson RJ. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton) 2004; 9:394-399
21. Iseki K, Oshiro S, Tozawa M et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hpertens Res 2001; 24:691-697
22. Sytjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000; 15:34-42
23. Bo S, Cavallo-Perin P, Gentile L et al. Hypouricemia and hyperuricemia in type 2 diabetes:two different phenotypes. Eur J Clin Invest 2001; 31:318-321
24. Siu YP, Leung KT, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Bis 2006; 47: 51-59
25. Chow KM, Kwan BC, Li PK et al. Asymptomatic isolated microscopic haematuria: long-term follow-up. Q J Med 2004; 97:739-745
26. Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56:161-165
1. LeveyAS, EckardtKU TsukamotoY, etal. Definition and classification of chronic kidney disease:apositionstatement from Kidney Disease:Improving Global Outcomes [J].Kidney Int,2005,67(6):2089-2100
2.赵静,孙伟,影响慢性肾脏病2-3期的危险因素及治疗进展.中国中西医结合肾病杂志.2009,10(3):362
3. Thomas M, Viberti G, Groop P, et al. Screening for chronic kidney disease in patients with diabetes:are we missing the point? Nat Clin Pract Nephol,2008,4:2-3.
4. EINahas AM, Bello AK. Chronic kidney disease:the global challenge. Lancet 2005; 365:331240.
5. Yoo KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabets in Asia. Lancet, 2006,368:1681-1688.
6. Sicree R, J Shaw, Zimmet P. Diabetes and impaired glucose tolerance.Diabets Atlas. 3rd edition. Brussels:International Daibetes Federation,2006:15-109.
7. Reutens AT, Prentice L, Atkins R. The epidemiology of diabetic kidney disease. The epidemiology of diabetes mellitus.2nd edition. Chichester: John Wiley & Sons Ltd,2008: 499-518.
8. White SL, Polkinghorne KR, Case A, et al. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust,2008,188:204-208.
9. Geriatrics.降低体重并减少食盐量能增强对血压的控制[J.]国外医学老年医学分册,1999,20(3)：140.
10. DasguptaI, PorterC, InnesA, etal. "Benign"hypertensive nephrosclerosis. QJM,2007, 100(2):113-119
11. WeirMR. The role of combination antihypertensive therapy in the pre-vention and treatmentof chronic kidney disease. Am J Hypertens,2005,18(4Pt2):S100-S105
12.徐晚虹,吕国荣,陈秋月,等.彩色多普勒血流显像检测吸烟对肾血流动力学的影响.中华超声影像学杂志,2001(2)：94.
13. Pinto Sietsma SJ, Mulder J, Janssen WM, et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med,2000,133 (8):585-591.
14.严豪,倪兆慧.吸烟对肾脏影响的研究进展.中国中西医结合肾病杂.2006(7)：550-551.
15.郑法雷,李雪梅.北京医学.2009,31(3)：170-172
16. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and anti2hypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 (suppl2):12290.
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification and stratification. Am J Kidney Dis 2002; 39 suppll 12246.
18. Ruggenenti P, Schieppati A, Perico N, Codreanu I, Peng, RemuzziG. Kidney prevention recipes for your office practice. Kidney Int 2005; 67 suppl)94:S136241
19.李鲁.社会医学[M].第二版.北京：人民卫生出版社：2003.65.
1. Levey AS,Eckardt KU,Tsukamoto Y,et al. Definition and classificationof chronic kidney disease apposition statement from Kidney Disease:Improving Global Outcomes (KDIGO)J. Kidney Int,2005,67(6):2089-2100.
2.上海市透析移植登记小组.1999年度上海市透析移植登记报告J.中华肾脏病杂志,2001,17(2)：83285.
3. CoreshJ,Wei GL McQuillan G,et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States:finding from the third National Health and Nutrition Examination Surve(1988-1994) J.Arch Intern Med,2001,16I(9):120721216.
4. 马迎春,左力,王海燕.肾小球滤过率测定存在的问题与对策N.中国医学论坛报,2006-11-09(3).
5.黄莉,潘松球,廖蕴华.慢性肾脏病流行情况的单中心研究J.中华肾病杂志,2006,22(6)：3732374.
6. Garg AX,Kiberd BA,Clark WF,et al.Alburninuria and renal insufficiencyprevalence guides population screening results from the NHANE-SIIIJ. Kindey Int,2002,61(6): 216522175.
7. CoreshJ,Astor BC,Green T,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population Third National Health and Nutrition Examination SurveyJ. Am J Kidney Dis,2003,41 (1):1212.
8. Levey AS, CoreshJ, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease:evaluation, classification, and stratification J.AmJ Kindey Dis, 2003,139(2):1372147.
9. Go AS,Chertow GM,Fan DJ, et al. Chronic kidney disease and the risks of death, cardio vascular events, and hospitalization J. N Engl J Med,2004,351 (13):129621305.
10. Chadban Si, Briganti EM, Kerr PG, etal. Prevalence of kidney damagein Australian adults:the Aus Diab kidney study J. J Am Soc Nephrol,2003,14 (7 Suppl 2):S1312S138.
11. Bron WW, Peters RM, Ohmit SE, etal, Early delection of kidney disease in community setting:the kidney early enaluation program J.Am J Kindey Dis,2003,42 (1):22235.
12. Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing endstage renal disease in a cohort of mass screening J. Kidney Int,1996,49 (3):8062813.
13. Ramirez SP, Mcclellan W, Port FK, et al. Risk factors for proteinuria in a large, multiracial, southeast Asian population J .J Am Soc Nephrol,2002,13 (7):190721917.
14. Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong asymptomatic renal population and evaluation (SHARE)programJ. Kidney Int,2005, (94):S362S40.
15.左力,王梅,王海燕.部分肾科医生在CKD诊断和治疗领域中的工作概况J.中华肾脏病杂志,2005,21(3)：1272128.
16.张路霞,王梅,王海燕,等.CKD的流行病学研究J.中华肾脏病杂志,2005,21(7)：4252427.
17.向红丁,吴纬,刘灿群,等.1996年全国糖尿病流行病学特点基线调查报告J.中国糖尿病杂志,1998,6(3)：1312133.
18.秦雯,陈楠.慢性肾脏病的全球流行状况J.国外医学内科学分册,2006,33(2)：81284.
19.中华医学会肾脏病分会透析移植登记工作组.1999年度全国透析移植登记报告J.中华肾脏病杂志,2001,17(2)：77278.
20. Hoy WE, Wang Z, Baker PR, etal. Reduction in natural death and renal failurefroma systematic screeningand treatment programin an Australian Aboriginal communityJ Kidney Int Suppl,2003, (83):S66-S73.
